A Cautiously Optimistic Outlook of a Designer Therapy for 1% of Duchenne Muscular Dystrophy Patients.
作者信息
Duan Dongsheng
机构信息
Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, Missouri, USA.
Department of Neurology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
出版信息
Hum Gene Ther. 2021 Sep;32(17-18):872-874. doi: 10.1089/hum.2021.29179.ddu.
Abstract
摘要
相似文献
1
A Cautiously Optimistic Outlook of a Designer Therapy for 1% of Duchenne Muscular Dystrophy Patients.针对1%杜氏肌营养不良症患者的定制疗法：谨慎乐观的前景展望
Hum Gene Ther. 2021 Sep;32(17-18):872-874. doi: 10.1089/hum.2021.29179.ddu.
2
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.靶向外显子跳跃作为杜氏肌营养不良症的一种潜在基因校正疗法。
Neuromuscul Disord. 2002 Oct;12 Suppl 1:S71-7. doi: 10.1016/s0960-8966(02)00086-x.
3
Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophy.将mRNA剪接作为杜氏肌营养不良症的潜在治疗靶点。
Discov Med. 2012 Jul;14(74):59-69.
4
Advances in Duchenne muscular dystrophy gene therapy.杜氏肌营养不良症基因治疗的进展
Nat Rev Genet. 2003 Oct;4(10):774-83. doi: 10.1038/nrg1180.
5
6
[Advances of treatment for Duchenne muscular dystrophy with exon skipping].[杜氏肌营养不良症外显子跳跃治疗进展]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Aug;28(4):406-8. doi: 10.3760/cma.j.issn.1003-9406.2011.04.010.
7
Challenges in the management of the child with Duchenne muscular dystrophy in a resource poor setting:a case report.资源匮乏地区杜氏肌营养不良症患儿管理面临的挑战：一例报告
Pan Afr Med J. 2014 Oct 30;19:227. doi: 10.11604/pamj.2014.19.227.3137. eCollection 2014.
8
The search for a cure for Duchenne muscular dystrophy (DMD).寻找杜氏肌营养不良症（DMD）的治疗方法。
Acta Myol. 2005 Dec;24(3):169-71.
9
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy.利益相关者合作克服孤儿药开发中的挑战：以杜氏肌营养不良症为例。
Lancet Neurol. 2016 Jul;15(8):882-890. doi: 10.1016/S1474-4422(16)30035-7.
10
Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?技术洞察：杜氏肌营养不良症的治疗——个性化医疗的契机？
Nat Clin Pract Neurol. 2008 Mar;4(3):149-58. doi: 10.1038/ncpneuro0737. Epub 2008 Feb 12.
本文引用的文献
1
A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment.一项长期前瞻性和回顾性比较研究的功能结局表明，长期依替膦酸酯治疗可延迟步行能力丧失和肺功能下降。
J Neuromuscul Dis. 2022;9(1):39-52. doi: 10.3233/JND-210665.
2
Exon-Skipping in Duchenne Muscular Dystrophy.外显子跳跃在杜氏肌营养不良症中的应用。
J Neuromuscul Dis. 2021;8(s2):S343-S358. doi: 10.3233/JND-210682.
3
Toward the correction of muscular dystrophy by gene editing.通过基因编辑纠正肌肉营养不良症。
Proc Natl Acad Sci U S A. 2021 Jun 1;118(22). doi: 10.1073/pnas.2004840117. Epub 2021 Apr 30.
4
Absence of Significant Off-Target Splicing Variation with a U7snRNA Vector Targeting Exon 2 Duplications.使用靶向外显子2重复序列的U7snRNA载体时无明显的脱靶剪接变异。
Hum Gene Ther. 2021 Nov;32(21-22):1346-1359. doi: 10.1089/hum.2020.315. Epub 2021 Jul 20.
5
Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated exon 2 skipping.临床前剂量递增研究确定了U7snRNA介导的外显子2跳跃的治疗范围。
Mol Ther Methods Clin Dev. 2021 Mar 23;21:325-340. doi: 10.1016/j.omtm.2021.03.014. eCollection 2021 Jun 11.
6
Duchenne muscular dystrophy.杜氏肌营养不良症。
Nat Rev Dis Primers. 2021 Feb 18;7(1):13. doi: 10.1038/s41572-021-00248-3.
7
Lack of Toxicity in Nonhuman Primates Receiving Clinically Relevant Doses of an AAV9.U7snRNA Vector Designed to Induce Exon 2 Skipping.在接受临床相关剂量的旨在诱导外显子 2 跳跃的 AAV9.U7snRNA 载体的非人类灵长类动物中无毒性。
Hum Gene Ther. 2021 Sep;32(17-18):882-894. doi: 10.1089/hum.2020.286. Epub 2021 May 7.
8
MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates.微小 RNA 介导的转基因表达抑制可减少灵长类动物 AAV 载体引起的背根神经节毒性。
Sci Transl Med. 2020 Nov 11;12(569). doi: 10.1126/scitranslmed.aba9188.
9
Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology.腺相关病毒诱导的背根神经节病理学。
Hum Gene Ther. 2020 Aug;31(15-16):808-818. doi: 10.1089/hum.2020.167. Epub 2020 Jul 31.
10
Therapeutic developments for Duchenne muscular dystrophy.杜氏肌营养不良症的治疗进展。
Nat Rev Neurol. 2019 Jul;15(7):373-386. doi: 10.1038/s41582-019-0203-3.
Zotero 插件